Hindalco Industries announced closure of trading window

Hindalco Industries announced closure of trading window

The intimation is as per the company’s code of conduct, formulated pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015

FPJ Web DeskUpdated: Thursday, December 29, 2022, 02:08 PM IST
article-image
Hindalco Industries announced closure of trading window | Image credit: Hindalco (Representative)

Hindalco Industries Limited has announced that, the trading window for dealing in securities of the company by Directors/ Designated Persons/ Connected Persons shall remain closed from Sunday, 1st January, 2023, till 48 hours after the announcement of financial results for the quarter ending on December 31, 2022, via an exchange filing.

The company stated the date of the Board Meeting for the declaration of the said results would be announced separately in due course.

The intimation is as per the company’s code of conduct, formulated pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, to regulate, monitor, and report trading by designated persons in listed or proposed to be listed securities of the company.

RECENT STORIES

FDs Losing Appeal, Investors Turning To Higher Returns; Here's Why The Trend Is Changing

FDs Losing Appeal, Investors Turning To Higher Returns; Here's Why The Trend Is Changing

Israel-Iran War: Soap, Oil, Biscuits Prices In India To Skyrocket; Raw Materials To Become...

Israel-Iran War: Soap, Oil, Biscuits Prices In India To Skyrocket; Raw Materials To Become...

Maruti Suzuki India Expects Vehicle Dispatches Through Railways To Increase 35% By 2030-31, Says...

Maruti Suzuki India Expects Vehicle Dispatches Through Railways To Increase 35% By 2030-31, Says...

If You Use Credit Card Of This Bank, Big Changes Are Coming; These Free Benefits Will End From July...

If You Use Credit Card Of This Bank, Big Changes Are Coming; These Free Benefits Will End From July...

India Pharma Market Grows 6.9%; Cardiac, Respiratory, Anti-Diabetes Therapies Outperform; Indian...

India Pharma Market Grows 6.9%; Cardiac, Respiratory, Anti-Diabetes Therapies Outperform; Indian...